Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Bolus

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44344   clinical trials with a EudraCT protocol, of which   7373   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    995 result(s) found for: Bolus. Displaying page 1 of 50.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2009-014741-89 Sponsor Protocol Number: 0916202 Start Date*: 2009-10-20
    Sponsor Name:Centre Hospitalier de Toulouse
    Full Title: Recherche de la DE90 d'un bolus de sufentanil pour l'analgésie des soins douloureux de nursing des malades intubés de réanimation
    Medical condition: patients intubés en réanimation sous ventilation mécanique
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-002926-67 Sponsor Protocol Number: 021048 Start Date*: 2005-12-16
    Sponsor Name:NV Organon
    Full Title: An open-label, randomized, phase IIIB, multicenter trial to evaluate the pharmacodynamic parameters of intubation bolus, and bolus and infusion maintenance doses of Zemuron® in pediatric and adoles...
    Medical condition: Not applicable
    Disease:
    Population Age: Newborns, Under 18 Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2012-001551-39 Sponsor Protocol Number: 00003 Start Date*: 2012-10-10
    Sponsor Name:Per H. Rosenberg
    Full Title: Sitooko laskimoon annettu rasvaemulsio laskimoon annettua lidokaiinia? - farmakokineettinen ja neu-rofysiologinen tutkimus terveillä vapaaehtoisilla koehenkilöillä
    Medical condition: Health volunteers used.
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-002318-37 Sponsor Protocol Number: J2H-MC-IUAA Start Date*: 2019-12-19
    Sponsor Name:Eli Lilly and Company Limited
    Full Title: A Study to Assess the Pharmacokinetics, Glucodynamics, Safety, and Tolerability of LY900027 in Patients with Type 1 Diabetes Mellitus on Continuous Subcutaneous Insulin Infusion Therapy
    Medical condition: Type I Diabetes Mellitus
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004861 10045228 Type I diabetes mellitus LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-000540-98 Sponsor Protocol Number: 2005/495-31 Start Date*: 2006-04-10
    Sponsor Name:Karolinska University Hospital
    Full Title: Substudie Bröstmärta provocerad med iv bolus adenosin injektion i huvudstudie: Jämförelse mellan aktiv och passiv fysisk träning för behandling av persisterande angina pectoris - en randomiserad st...
    Medical condition: Refractory angina pectoris. Testing of sensitivity of chest pain provoked by iv bolus of adenosin before and after a training period with EECP (Enhanced External Counterpulsation) or physical exerc...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-002940-28 Sponsor Protocol Number: ISRCTN46528154 Start Date*: 2006-10-09
    Sponsor Name:ICIN [...]
    1. ICIN
    2. UMCG, Van Buchem Stichting
    Full Title: HEBE III: A prospective, randomised, double blind, placebo controlled clinical study to examine the effects of a single bolus erythropoietin on left ventricular function in patients with an acute m...
    Medical condition: Patients with a successful primary PCI (TIMI 2/3) for a first acute myocardial infarction
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-021390-36 Sponsor Protocol Number: buspar2010 Start Date*: 2010-09-07
    Sponsor Name:uzleuven
    Full Title: The Effect of Acute Intake of Oral Buspirone Hydrochloride on Esophageal Motility, Bolus Transit and Symptoms of Dysphagia, in Patients with Ineffective Esophageal Motility: A Pilot, Open-label, Si...
    Medical condition: Ineffective Esophageal Motility
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2006-004799-11 Sponsor Protocol Number: 2006OB01 Start Date*: 2007-11-29
    Sponsor Name:Coombe Women's Hospital
    Full Title: A randomised trial of oxytocin bolus versus oxytocin bolus and infusion for the control of blood loss at elective caesarean section.
    Medical condition: Elective lower segment caesarean section
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: IE (Completed)
    Trial results: View results
    EudraCT Number: 2014-001005-41 Sponsor Protocol Number: fluresstudy Start Date*: 2014-12-10
    Sponsor Name:Ghent University Hospital
    Full Title: Evaluation of FLuid REsuscitation with Sterofundin ® ISO (Ringerfundin), Plasma-Lyte® or NaCl 0.9%. (FluReS study)
    Medical condition: hypovolemia-->need for fluid therapy
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2015-003761-28 Sponsor Protocol Number: VP-00525 Start Date*: 2015-12-22
    Sponsor Name:Calibra Medical, Inc.
    Full Title: GLYCEMIC CONTROL AND TREATMENT SATISFACTION USING FINESSE VERSUS PEN FOR INITIATING BOLUS INSULIN DOSING IN TYPE 2 DIABETES MELLITUS PATIENTS NOT ACHIEVING GLYCEMIC TARGETS ON BASAL INSULIN WITH/WI...
    Medical condition: Type 2 Diabetes Mellitus (T2DM)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2017-002508-29 Sponsor Protocol Number: CEFTAROPROPH Start Date*: 2018-02-09
    Sponsor Name:MedUni Vienna, Dept of Anesthesia, Critical Care, Div. of Cardiothoracic and Vascular Anesthesia
    Full Title: Ceftaroline (Zinforo®) as antibiotic prophylaxis for CABG-surgery: An In-vivo microdialysis study
    Medical condition: Antibiotic prophylaxis for CABG surgery
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10036894 Prophylactic antibiotic therapy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-000303-42 Sponsor Protocol Number: 9050 Start Date*: 2006-09-25
    Sponsor Name:ISALA KLINIEKEN
    Full Title: A randomized, double blind controlled trial evaluating the benefits of early up-front-loaded high dose Tirofiban in the treatment of patients with ST-segment elevation myocardial infarction, who ar...
    Medical condition: acute myocardial infarction with ST segment elevation
    Disease: Version SOC Term Classification Code Term Level
    8.1 10064345 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) BE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2021-003427-14 Sponsor Protocol Number: AHUS_PAL_21_01 Start Date*: 2021-12-20
    Sponsor Name:Akershus University Hospital
    Full Title: A randomized controlled trial of subcutaneous versus intravenous morphine when switching from oral to parenteral route in palliative cancer patients
    Medical condition: Cancer pain not responding to oral opioids in palliative cancer patient, where switching to the parenteral route is indicated.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NO (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-006172-35 Sponsor Protocol Number: 2005/EMER/18 Start Date*: 2006-07-17
    Sponsor Name:North Hampshire Hospital NHS Trust
    Full Title: A Randomised, Prospective, Double Blinded, Placebo Controlled Trial to Determine the Efficacy of Continuous Infusion Ankle Block Compared to Standard Single Bolus Block in the Management of Postope...
    Medical condition: Any Orthopaedic condition which would require ankle or hind foot surgery under Mr. James Calder at North Hampshire Hospital, Basingstoke.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2005-005946-38 Sponsor Protocol Number: IOM/BRA/038 Start Date*: Information not available in EudraCT
    Sponsor Name:Bracco ALTANA Pharma GmbH
    Full Title: A DOUBLE-BLIND INTER-INDIVIDUAL COMPARISON OF IOMEPROL 300 AND IOMEPROL 400 IN MULTI-DETECTOR CT ANGIOGRAPHY (MDCTA) OF PERIPHERAL ARTERIES
    Medical condition: Medical condition: indication for computed tomographic angiography of the peripheral arteries, in particular for diagnosis of peripheral arterial disease
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-018586-39 Sponsor Protocol Number: 2010/0121 Start Date*: 2010-06-01
    Sponsor Name:Medical Department M (Endocrinology & Diabetes)
    Full Title: Diurnal variation of exogenous peptides
    Medical condition: Adults with growth hormone disease (AGHD).
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-001785-26 Sponsor Protocol Number: 14-505 Start Date*: 2016-02-15
    Sponsor Name:Portola Pharmaceuticals, Inc.
    Full Title: Prospective, Open-label Study of Andexanet Alfa in Patients Receiving a Factor Xa Inhibitor who Have Acute Major Bleeding (ANNEXA-4).
    Medical condition: Uncontrolled bleeding in patients who have taken either a direct factor Xa inhibitor (novel oral anticoagulants) or an indirect factor Xa inhibitor (low molecular weight heparins).
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000022097 10075279 Anticoagulant reversal therapy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) GB (Completed) BE (Completed) DE (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2016-001839-13 Sponsor Protocol Number: AGO/2016/006 Start Date*: 2016-06-07
    Sponsor Name:Ghent University Hospital
    Full Title: Influence of a bolus administration of ephedrine and phenylephrine on spinal oxygen saturation, measured with NIRS.
    Medical condition: Hypotension during surgery Paraplegia and/or paraparesis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed)
    Trial results: View results
    EudraCT Number: 2013-002437-37 Sponsor Protocol Number: 13-1-033 Start Date*: 2014-07-31
    Sponsor Name:Maastricht University Medical Centre
    Full Title: Effects on Intra-Coronary Attenuation using low iodine concentrations (240 mg, 300 mg and 370 mg iodine per ml) while maintaining identical IDR
    Medical condition: atypical or typical complaints of angina pectoris with no previous cardiovascular medical history low to intermediate risk for atherosclerosis referred for coronary CTA to rule out CAD
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2014-004078-40 Sponsor Protocol Number: CQR14002 Start Date*: 2015-01-28
    Sponsor Name:CeQur Corp.
    Full Title: A Prospective, Single Center, Observational Study to Assess the Performance, Safety, and Patient Reported Outcomes of Insulin Delivery with PaQ® in Patients with Type 2 Diabetes Mellitus
    Medical condition: Type 2 diabetes mellitus
    Disease: Version SOC Term Classification Code Term Level
    17.1 10027433 - Metabolism and nutrition disorders 10053247 Insulin-requiring type 2 diabetes mellitus PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon Jun 23 22:23:04 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA